Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease

Overview

Journal Arthritis Rheumatol

Publisher Wiley

Specialty Rheumatology

Date 2015 Sep 12

PMID 26360820

Citations 54

Authors

Fabian A Mendoza

Sonsoles Piera-Velazquez

John L Farber

Carol Feghali-Bostwick

Sergio A Jimenez

Affiliations

Soon will be listed here.

Abstract

Objective: To examine whether lung endothelial cells (ECs) from patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) express mesenchymal cell-specific proteins and gene transcripts, indicative of the occurrence of endothelial-to-mesenchymal phenotypic transition (EndoMT).

Methods: Lung tissue from 6 patients with SSc-associated pulmonary fibrosis was examined by histopathology and immunohistochemistry. Confocal laser microscopy was utilized to assess the simultaneous expression of EC and myofibroblast molecular markers. CD31+CD102+ ECs were isolated from the lung tissue of 2 patients with SSc-associated ILD and 2 normal control subjects, and the expression of EC and mesenchymal cell markers and other relevant genes was analyzed by quantitative polymerase chain reaction, immunofluorescence microscopy, and Western blotting.

Results: Immunohistochemical staining revealed cells expressing the EC-specific marker CD31 in the subendothelial, perivascular, and parenchymal regions of the lungs from all SSc patients. Confocal microscopy identified cells displaying simultaneous expression of von Willebrand factor and α-smooth muscle actin in small and medium-sized arterioles in the SSc lung tissue but not in normal control lungs. CD31+CD102+ ECs isolated from SSc lungs expressed high levels of mesenchymal cell-specific genes (type I collagen, type III collagen, and fibronectin), EC-specific genes (type IV collagen and VE-cadherin), profibrotic genes (transforming growth factor β1 and connective tissue growth factor), and genes encoding EndoMT-related transcription factors (TWIST1 and SNAI2).

Conclusion: Cells coexpressing EC- and mesenchymal cell-specific molecules are present in the lungs of patients with SSc-associated ILD. CD31+CD102+ ECs isolated from SSc lungs simultaneously expressed mesenchymal cell- and EC-specific transcripts and proteins. Collectively, these observations demonstrate the occurrence of EndoMT in the lungs of patients with SSc-associated ILD.

Citing Articles

The role of vascularity and the fibrovascular interface in interstitial lung diseases.

Dietrich J, Kang A, Tielemans B, Verleden S, Khalil H, Langer F Eur Respir Rev. 2025; 34(175).

PMID: 39909504 PMC: 11795288. DOI: 10.1183/16000617.0080-2024.

CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms.

Greenman R, Weston C Cells. 2025; 14(2).

PMID: 39851534 PMC: 11763828. DOI: 10.3390/cells14020105.

Virus-Induced MicroRNA Modulation and Systemic Sclerosis Disease.

Soffritti I, DAccolti M, Bini F, Mazziga E, Di Luca D, Maccari C Biomedicines. 2024; 12(6).

PMID: 38927567 PMC: 11202132. DOI: 10.3390/biomedicines12061360.

Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis-Associated and Idiopathic Pulmonary Hypertension.

Zhou Y, Tabib T, Huang M, Yuan K, Kim Y, Morse C Arterioscler Thromb Vasc Biol. 2024; 44(8):e210-e225.

PMID: 38841857 PMC: 11269037. DOI: 10.1161/ATVBAHA.123.320005.

Endothelial to mesenchymal transition: at the axis of cardiovascular health and disease.

Hall I, Kishta F, Xu Y, Baker A, Kovacic J Cardiovasc Res. 2024; 120(3):223-236.

PMID: 38385523 PMC: 10939465. DOI: 10.1093/cvr/cvae021.

References

Matucci-Cerinic M, Kahaleh B, Wigley F . Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013; 65(8):1953-62. DOI: 10.1002/art.37988. View

Gilbane A, Denton C, Holmes A . Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther. 2013; 15(3):215. PMC: 4060542. DOI: 10.1186/ar4230. View

Falke L, Gholizadeh S, Goldschmeding R, Kok R, Nguyen T . Diverse origins of the myofibroblast—implications for kidney fibrosis. Nat Rev Nephrol. 2015; 11(4):233-44. DOI: 10.1038/nrneph.2014.246. View

LeBleu V, Taduri G, OConnell J, Teng Y, Cooke V, Woda C . Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013; 19(8):1047-53. PMC: 4067127. DOI: 10.1038/nm.3218. View

Medici D, Potenta S, Kalluri R . Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem J. 2011; 437(3):515-20. PMC: 4457510. DOI: 10.1042/BJ20101500. View

McAnulty R . Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol. 2007; 39(4):666-71. DOI: 10.1016/j.biocel.2006.11.005. View

Veraldi K, Hsu E, Feghali-Bostwick C . Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease. Curr Rheumatol Rep. 2010; 12(1):19-25. DOI: 10.1007/s11926-009-0071-8. View

Herzog E, Bucala R . Fibrocytes in health and disease. Exp Hematol. 2010; 38(7):548-56. PMC: 3136351. DOI: 10.1016/j.exphem.2010.03.004. View

Del Galdo F, Sotgia F, de Almeida C, Jasmin J, Musick M, Lisanti M . Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum. 2008; 58(9):2854-65. PMC: 2770094. DOI: 10.1002/art.23791. View

10.

Zeisberg E, Tarnavski O, Zeisberg M, Dorfman A, McMullen J, Gustafsson E . Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007; 13(8):952-61. DOI: 10.1038/nm1613. View

11.

Li J, Qu X, Bertram J . Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol. 2009; 175(4):1380-8. PMC: 2751535. DOI: 10.2353/ajpath.2009.090096. View

12.

Arciniegas E, Neves C, Carrillo L, Zambrano E, Ramirez R . Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development. Endothelium. 2005; 12(4):193-200. DOI: 10.1080/10623320500227283. View

13.

Nolan T, Hands R, Bustin S . Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2007; 1(3):1559-82. DOI: 10.1038/nprot.2006.236. View

14.

Li Z, Jimenez S . Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro. Arthritis Rheum. 2011; 63(8):2473-83. PMC: 3134600. DOI: 10.1002/art.30317. View

15.

Hashimoto N, Phan S, Imaizumi K, Matsuo M, Nakashima H, Kawabe T . Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2009; 43(2):161-72. PMC: 2937229. DOI: 10.1165/rcmb.2009-0031OC. View

16.

Goumans M, van Zonneveld A, Ten Dijke P . Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis?. Trends Cardiovasc Med. 2009; 18(8):293-8. DOI: 10.1016/j.tcm.2009.01.001. View

17.

Strieter R, Keeley E, Hughes M, Burdick M, Mehrad B . The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol. 2009; 86(5):1111-8. PMC: 2774878. DOI: 10.1189/jlb.0309132. View

18.

Good R, Gilbane A, Trinder S, Denton C, Coghlan G, Abraham D . Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension. Am J Pathol. 2015; 185(7):1850-8. DOI: 10.1016/j.ajpath.2015.03.019. View

19.

Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15(3):178-96. PMC: 4240281. DOI: 10.1038/nrm3758. View

20.

Varga J, Abraham D . Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007; 117(3):557-67. PMC: 1804347. DOI: 10.1172/JCI31139. View